- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Biomea Fusion Stock (NASDAQ:BMEA), Quotes and News Summary
Biomea Fusion Stock (NASDAQ: BMEA)
| Day Range9.22 - 10.19 | 52 Wk Range2.84 - 14.2 | Open / Close9.28 / 9.78 | Float / Outstanding12.9M / 29.3M |
| Vol / Avg.526.1K / 138.6K | Mkt Cap286.5M | P/E- | 50d Avg. Price11.54 |
| Div / Yield- | Payout Ratio- | Total Float12.9M | EPS-0.59 |
Earnings
see more| Q3 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-11-02 | ||||||
| REV | |||||||
| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.600 | -0.590 | 0.0100 | ||||
| REV | 0 |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Biomea Fusion Questions & Answers
You can purchase shares of Biomea Fusion (NASDAQ: BMEA) through any online brokerage.
Other companies in Biomea Fusion’s space includes: Outlook Therapeutics (NASDAQ:OTLK), AVEO Pharmaceuticals (NASDAQ:AVEO), Vaxxinity (NASDAQ:VAXX), 4D Molecular Therapeutics (NASDAQ:FDMT) and Voyager Therapeutics (NASDAQ:VYGR).
The latest price target for Biomea Fusion (NASDAQ: BMEA) was reported by HC Wainwright & Co. on Thursday, June 2, 2022. The analyst firm set a price target for 16.00 expecting BMEA to rise to within 12 months (a possible 63.60% upside). 3 analyst firms have reported ratings in the last year.
The stock price for Biomea Fusion (NASDAQ: BMEA) is $9.78 last updated September 30, 2022, 8:00 PM UTC.
There are no upcoming dividends for Biomea Fusion.
Biomea Fusion’s Q3 earnings are confirmed for Wednesday, November 2, 2022.
There is no upcoming split for Biomea Fusion.
Biomea Fusion is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.